SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nurul H. M. Yusoff, Farah W. Suhaimi, Raja K. Vadivelu, Zurina Hassan, Anne Rümler, Andrea Rotter, Davide Amato, Hans C. Dringenberg, Sharif M. Mansor, Visweswaran Navaratnam, Christian P. Müller, Abuse potential and adverse cognitive effects of mitragynine (kratom), Addiction Biology, 2015, 20, 4
  2. 2
    Cédric Mazoyer, Jérémy Carlier, Caroline Sastre, Vincent Di Fazio, Cannabinoïdes de synthèse : méthodes analytiques, Toxicologie Analytique et Clinique, 2015,

    CrossRef

  3. 3
    Akira Namera, Maho Kawamura, Akihiro Nakamoto, Takeshi Saito, Masataka Nagao, Comprehensive review of the detection methods for synthetic cannabinoids and cathinones, Forensic Toxicology, 2015, 33, 2, 175

    CrossRef

  4. 4
    Joanna Znaleziona, Pavlína Ginterová, Jan Petr, Peter Ondra, Ivo Válka, Juraj Ševčík, Jan Chrastina, Vítězslav Maier, Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques – a review, Analytica Chimica Acta, 2015, 874, 11

    CrossRef

  5. 5
    Travis W. Grim, Jason M. Wiebelhaus, Anthony J. Morales, S. Stevens Negus, Aron H. Lichtman, Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice, Drug and Alcohol Dependence, 2015, 150, 31

    CrossRef

  6. 6
    Karim M. Abdel-Hay, Jack DeRuiter, Forrest Smith, Tarek S. Belal, C. Randall Clark, GC–MS analysis of the regioisomeric methoxy- and methyl-benzoyl-1-pentylindoles: Isomeric synthetic cannabinoids, Science & Justice, 2015,

    CrossRef

  7. 7
    Bjoern Moosmann, Verena Angerer, Volker Auwärter, Inhomogeneities in herbal mixtures: a serious risk for consumers, Forensic Toxicology, 2015, 33, 1, 54

    CrossRef

  8. 8
    Laura A. Ciolino, Quantitation of Synthetic Cannabinoids in Plant Materials Using High Performance Liquid Chromatography with UV Detection (Validated Method), Journal of Forensic Sciences, 2015, 60, 4
  9. 9
    Marisol S. Castaneto, Karl B. Scheidweiler, Adarsh Gandhi, Ariane Wohlfarth, Kevin L. Klette, Thomas M. Martin, Marilyn A. Huestis, Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens, Drug Testing and Analysis, 2015, 7, 6
  10. 10
    Darshan Singh, Christian P. Müller, Balasingam K. Vicknasingam, Sharif M. Mansor, Social Functioning of Kratom(Mitragyna speciosa)Users in Malaysia, Journal of Psychoactive Drugs, 2015, 47, 2, 125

    CrossRef

  11. 11
    Samuel D. Banister, Jordyn Stuart, Trent Conroy, Mitchell Longworth, Madhura Manohar, Corinne Beinat, Shane M. Wilkinson, Richard C. Kevin, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor, Michael Kassiou, Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues, Forensic Toxicology, 2015, 33, 2, 355

    CrossRef

  12. 12
    Tim Sobolevsky, Ilya Prasolov, Grigory Rodchenkov, Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue, Drug Testing and Analysis, 2015, 7, 2
  13. 13
    Ioan Marginean, Walter F. Rowe, Ira S. Lurie, The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs, Forensic Science International, 2015, 249, 83

    CrossRef

  14. 14
    Vadim Shevyrin, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Yuri Morzherin, Yuri Shafran, 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: Chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures, Forensic Science International, 2014, 242, 72

    CrossRef

  15. 15
    Laura M. Huppertz, Stefan Kneisel, Volker Auwärter, Jürgen Kempf, A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization, Journal of Mass Spectrometry, 2014, 49, 2
  16. 16
    Ken Yasukawa, Cannabinoids as seed compounds for the cancer treatment, Forensic Toxicology, 2014, 32, 2, 189

    CrossRef

  17. 17
    S Grassin-Delyle, E Naline, A Buenestado, C Faisy, J-C Alvarez, H Salvator, C Abrial, C Advenier, L Zemoura, P Devillier, Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors, British Journal of Pharmacology, 2014, 171, 11
  18. 18
    Moonhee Jang, Wonkyung Yang, Ilchung Shin, Hyeyoung Choi, Hyejin Chang, Eunmi Kim, Determination of AM-2201 metabolites in urine and comparison with JWH-018 abuse, International Journal of Legal Medicine, 2014, 128, 2, 285

    CrossRef

  19. 19
    A. Z. Temerdashev, I. M. Grigor’ev, I. V. Rybal’chenko, Evolution of new narcotic substances and methods of their determination, Journal of Analytical Chemistry, 2014, 69, 9, 817

    CrossRef

  20. 20
    G. Behonick, K. G. Shanks, D. J. Firchau, G. Mathur, C. F. Lynch, M. Nashelsky, D. J. Jaskierny, C. Meroueh, Four Postmortem Case Reports with Quantitative Detection of the Synthetic Cannabinoid, 5F-PB-22, Journal of Analytical Toxicology, 2014, 38, 8, 559

    CrossRef

  21. 21
    Nico Langer, Rainer Lindigkeit, Hans-Martin Schiebel, Ludger Ernst, Till Beuerle, Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: A snapshot of the German situation in the autumn of 2012, Drug Testing and Analysis, 2014, 6, 1-2
  22. 22
    R. Marshell, T. Kearney-Ramos, L.K. Brents, W.S. Hyatt, S. Tai, P.L. Prather, W.E. Fantegrossi, In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection, Pharmacology Biochemistry and Behavior, 2014, 124, 40

    CrossRef

  23. 23
    Darshan Singh, Christian P. Müller, Balasingam K. Vicknasingam, Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users, Drug and Alcohol Dependence, 2014, 139, 132

    CrossRef

  24. 24
    Ariane Wohlfarth, Shaokun Pang, Mingshe Zhu, Adarsh S Gandhi, Karl B Scheidweiler, Marilyn A Huestis, Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS, Bioanalysis, 2014, 6, 9, 1187

    CrossRef

  25. 25
    Adarsh S Gandhi, Mingshe Zhu, Shaokun Pang, Ariane Wohlfarth, Karl B Scheidweiler, Marilyn A Huestis, Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS, Bioanalysis, 2014, 6, 11, 1471

    CrossRef

  26. 26
    Jenny L. Wiley, Julie A. Marusich, John W. Huffman, Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids, Life Sciences, 2014, 97, 1, 55

    CrossRef

  27. 27
    Jane Carlisle Maxwell, Psychoactive substances—Some new, some old: A scan of the situation in the U.S., Drug and Alcohol Dependence, 2014, 134, 71

    CrossRef

  28. 28
    Li Li, Ira S. Lurie, Screening of seized emerging drugs by ultra-high performance liquid chromatography with photodiode array ultraviolet and mass spectrometric detection, Forensic Science International, 2014, 237, 100

    CrossRef

  29. 29
    Mahmoud A. ElSohly, Waseem Gul, Amira S. Wanas, Mohamed M. Radwan, Synthetic cannabinoids: Analysis and metabolites, Life Sciences, 2014, 97, 1, 78

    CrossRef

  30. 30
    Susana Sadler Simões, Inês Silva, Antonio Castañera Ajenjo, Mário João Dias, Validation and application of an UPLC–MS/MS method for the quantification of synthetic cannabinoids in urine samples and analysis of seized materials from the Portuguese market, Forensic Science International, 2014, 243, 117

    CrossRef

  31. 31
    A. Louis, B. L. Peterson, F. J. Couper, XLR-11 and UR-144 in Washington State and State of Alaska Driving Cases, Journal of Analytical Toxicology, 2014, 38, 8, 563

    CrossRef

  32. 32
    Michael B. Gatch, Michael J. Forster, Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice, Behavioural Pharmacology, 2014, 25, 8, 750

    CrossRef

  33. 33
    Kratom and Other Mitragynines, 2014,

    CrossRef

  34. 34
    J. K. Yeakel, B. K. Logan, Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving, Journal of Analytical Toxicology, 2013, 37, 8, 547

    CrossRef

  35. 35
    Jenny L. Wiley, Julie A. Marusich, Timothy W. Lefever, Megan Grabenauer, Katherine N. Moore, Brian F. Thomas, Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles, Neuropharmacology, 2013, 75, 145

    CrossRef

  36. 36
    Débora González, Mireia Ventura, Fernando Caudevilla, Marta Torrens, Magi Farre, Consumption of new psychoactive substances in a Spanish sample of research chemical users, Human Psychopharmacology: Clinical and Experimental, 2013, 28, 4
  37. 37
    Zurina Hassan, Mustapha Muzaimi, Visweswaran Navaratnam, Nurul H.M. Yusoff, Farah W. Suhaimi, Rajakumar Vadivelu, Balasingam K. Vicknasingam, Davide Amato, Stephan von Hörsten, Nurul I.W. Ismail, Nanthini Jayabalan, Ammar I. Hazim, Sharif M. Mansor, Christian P. Müller, From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction, Neuroscience & Biobehavioral Reviews, 2013, 37, 2, 138

    CrossRef

  38. 38
    K. G. Shanks, G. S. Behonick, T. Dahn, A. Terrell, Identification of Novel Third-Generation Synthetic Cannabinoids in Products by Ultra-Performance Liquid Chromatography and Time-of-Flight Mass Spectrometry, Journal of Analytical Toxicology, 2013, 37, 8, 517

    CrossRef

  39. 39
    Pierce Kavanagh, Andrej Grigoryev, Sergey Savchuk, Irina Mikhura, Andrew Formanovsky, UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products, Drug Testing and Analysis, 2013, 5, 8